Ballard Spahr advised EF Hutton on the deal. EF Hutton, a division of Benchmark Investments, LLC, acted as sole book-running manager for Vision Sensing Acquisition Corp.,...
You must be a Standard 1 Year member to access this content.
Ballard Spahr advised Pyramid Biosciences on the deal. Clinical-stage biotechnology company Pyramid Biosciences, Inc. announced the development of a global licensing deal for two cancer therapies worth...
You must be a Standard 1 Year member to access this content.
Morrison & Foerster advised Greenlane Holdings on the deal while Ballard Spahr represented DaVinci. Greenlane Holdings, Inc., a global house of brands and one of the...
You must be a Standard 1 Year member to access this content.
Ballard Spahr advised PA Natural Medicine LLC on the deal. Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF), a vertically-integrated cannabis multi-state operator (MSO), has closed, through a...
You must be a Standard 1 Year member to access this content.
